Details for New Drug Application (NDA): 210466
✉ Email this page to a colleague
NDA 210466 describes DOFETILIDE, which is a drug marketed by Accord Hlthcare, Bionpharma, Dr Reddys Labs Sa, Granules, MSN, Novast Labs, Prinston Inc, Rk Pharma, Sigmapharm Labs Llc, Strides Pharma, Sun Pharm, and Teva Pharms Usa, and is included in twelve NDAs. It is available from fourteen suppliers. Additional details are available on the DOFETILIDE profile page.
The generic ingredient in DOFETILIDE is dofetilide. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dofetilide profile page.
The generic ingredient in DOFETILIDE is dofetilide. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dofetilide profile page.
Summary for 210466
| Tradename: | DOFETILIDE |
| Applicant: | Sun Pharm |
| Ingredient: | dofetilide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 210466
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DOFETILIDE | dofetilide | CAPSULE;ORAL | 210466 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-061 | 47335-061-79 | 4 BLISTER PACK in 1 CARTON (47335-061-79) / 10 CAPSULE in 1 BLISTER PACK (47335-061-66) |
| DOFETILIDE | dofetilide | CAPSULE;ORAL | 210466 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-061 | 47335-061-86 | 60 CAPSULE in 1 BOTTLE (47335-061-86) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.125MG | ||||
| Approval Date: | Oct 9, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.25MG | ||||
| Approval Date: | Oct 9, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Oct 9, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
